Drug discovery > Pre-Clinical Development Products & Reviews

ADAMII CD3/CD4/CD8 Kit is compatible with ADAM?. It is used for counting CD3+,CD3+CD4+, and CD3+CD8+ cell that can be used in research laboratory.

ADAMII-LS is an image-based fluorescence cell analyzer providing high quality analysis features and accurate results.

ADAMII CDx is an image-based immunophenotyping instrument. ADAMII-CDx, all-in-one system with 4-channel (Bright field and 3 fluorescent channels) for cell therapy R&D and manufacturing process. 

The EVE™ HT FL is a high-throughput automated fluorescence cell counter equipped with bright field and two fluorescence channels (AO/DAPI). In just 3 minutes, up to 48 samples can be counted and analyzed. EVE™ HT FL delivers brilliant precision and accuracy, making it the optimal choice for both cell lines and primary cell analysis in a variety of applications.

Save time automating manual capping and decapping processes in your lab with the Scinomix RapidCAP2 benchtop system.The RapidCAP2 is compatible with a range of 0.5 mL to 2.0 mL inexpensive bulk cryovials.

Metabolite Identification Software That Makes Decisions Easier

Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7 Guidelines

Calculate drug toxicity and safety endpoints

Calculate physicochemical properties from structure

Elucidate complex structures from experimental data with the help of expert algorithms

Predict pharmacokinetic properties from structure

SMALL FOOTPRINT. RELIABLE RESULTS. COMPLETE ELISA AUTOMATION.

VISUALIZE WHAT PLANT BIOLOGY HAS BEEN HIDING  

Greiner Bio-One  offers a comprehensive range of state-of-the-art solutions for large biorepository cryo storage

Features: Ergonomic design Reliably decaps and caps eight Cryo.s™ Biobanking tubes in parallel Stable stand for storage of device and contamination-free parking of screw caps Eight individual motors for precise application of 7 Ncm torque for tube closure  

Compact construction, broad temperature range and multiple block options make the MiniBlock Heater the perfect tool for laboratory incubations.

With a 4 mm orbit and fixed speed of 2800 rpm, even the largest samples are vortexed instantly.

An innovative technology termed isotopic ratio outlier analysis (IROA) was developed to overcome the analytical challenges associated with current, stable isotope labeled compounds used in untargeted /targeted metabolic profiling.   These challenges minimally pertain to analytical variance, artifactual peaks, and metabolite identification. The IROA method uses metabolic incorporation of heavy (95% 13C) and light (5%…

Isotope labeled products for Bio-NMR studies

CIL offers a comprehensive listing of isotope-enriched products used to study the structure and dynamics of protein and nucleic acids using nuclear magnetic resonance (NMR). 

Ultravap™ Levante Nitrogen Blow-Down Sample Concentrator

OXM causes weight loss via suppression of food intake and increase in energy expenditure. OXM administration was also reported to increase heart-rate in mice. Besides regulating glucose homeostasis in monogastric animals, OXM also increases the concentration of insulin and glucose in plasma of Holstein cattle under normal physiological conditions. It has been shown that Type 2 diabetes patients have lower levels of OXM and lev…

The Ansh Labs Bioactive IGF-I kit uses a highly sensitive two-site antibody method which allows detection of bioactive IGF-I. This assay enables accurate measurement and differentiation of bioactive IGF-I from total IGF-I levels. Assessment of bioactive to total IGF-I ratio will be informative and advance our understanding of IGF-I function and regulation in different physiological and disease states.

The Total IGF-I immunoassay is a direct detection method which eliminates potential altering of sample matrix from size-exclusion chromatography or filtration methods.  

The ratio of Total to Intact IGFBP-4 concentration measured in individual subjects over time will help normalizes the IGFBP-4 variability between subjects and also increase the detection rate of increased PAPP-A activity in myocardial infarction subjects.